TFX benefits from a diversified product portfolio in the fourth quarter of 2024, with strength in the Surgical and ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...

Teleflex (NYSE: TFX) announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly ...

Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.

Teleflex (NYSE:TFX) stock drops as the company posts Q4 results and plans to spin off its Urology, Acute Care, and OEM units ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Raymond James downgraded Teleflex (TFX) to Market Perform from Outperform without a price target The firm likes the company’s active portfolio ...

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex separately reported today fourth quarter and full-year 2024 financial results and announced its entry into a ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...